Advertisement
UK markets open in 42 minutes
  • NIKKEI 225

    38,758.00
    +521.93 (+1.37%)
     
  • HANG SENG

    18,502.16
    -76.14 (-0.41%)
     
  • CRUDE OIL

    78.65
    +0.17 (+0.22%)
     
  • GOLD FUTURES

    2,328.00
    -3.20 (-0.14%)
     
  • DOW

    38,852.27
    +176.59 (+0.46%)
     
  • Bitcoin GBP

    50,681.07
    -680.48 (-1.32%)
     
  • CMC Crypto 200

    1,367.71
    +2.59 (+0.19%)
     
  • NASDAQ Composite

    16,349.25
    +192.92 (+1.19%)
     
  • UK FTSE All Share

    4,469.09
    +22.94 (+0.52%)
     

Collegium to Report First Quarter 2024 Financial Results on May 9, 2024

Collegium Pharmaceutical, Inc.
Collegium Pharmaceutical, Inc.

STOUGHTON, Mass., April 25, 2024 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading, diversified specialty pharmaceutical company committed to improving the lives of people living with serious medical conditions, today announced that it will report first quarter 2024 financial results after the market closes on Thursday, May 9, 2024. Following the release of the financials, the Company will host a live conference call and webcast at 4:30 p.m. ET.

Conference Call Information 
To access the conference call, please dial (877) 407-8037 (U.S.) or (201) 689-8037 (International) and reference the “Collegium Pharmaceutical Q1 2024 Earnings Call.” An audio webcast will be accessible from the Investors section of the Company’s website: www.collegiumpharma.com. The webcast will be available for replay on the Company’s website approximately two hours after the event.

About Collegium Pharmaceutical, Inc.
Collegium is a leading, diversified specialty pharmaceutical company committed to improving the lives of people living with serious medical conditions. Collegium’s headquarters are located in Stoughton, Massachusetts. For more information, please visit the Company’s website at www.collegiumpharma.com.

ADVERTISEMENT

Investor Contact:
Christopher James, M.D.
Vice President, Investor Relations
ir@collegiumpharma.com

Media Contact:
Marissa Samuels
Vice President, Corporate Communications
communications@collegiumpharma.com